Nuvotec뉴보텍
060260 · KOSDAQ · ₩060260 · 뉴보텍
₩743▼ ₩5 (0.67%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩43B | ₩43B | ₩49B | ₩46B | ₩47B |
| Cost of sales | ₩30B | ₩29B | ₩34B | ₩35B | ₩39B |
| Gross profit | ₩14B | ₩14B | ₩15B | ₩11B | ₩8.4B |
| Operating income | ₩1.3B | ₩2.6B | −₩110M | ₩1.3B | −₩2.2B |
| Net income | ₩1.9B | ₩1.7B | −₩6.4B | −₩2B | −₩8.6B |
| Net income to shareholders | ₩1.9B | ₩1.7B | −₩6.4B | −₩2B | −₩8.6B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩56B | ₩50B | ₩45B | ₩52B | ₩53B |
| Current assets | ₩30B | ₩25B | ₩19B | ₩22B | ₩25B |
| Cash and equivalents | ₩4.6B | ₩9.7B | ₩2.8B | ₩3.6B | ₩9.3B |
| Total liabilities | ₩33B | ₩28B | ₩32B | ₩34B | ₩39B |
| Current liabilities | ₩27B | ₩24B | ₩28B | ₩31B | ₩31B |
| Borrowings | ₩14B | ₩13B | ₩16B | ₩19B | ₩25B |
| Total equity | ₩23B | ₩21B | ₩13B | ₩19B | ₩14B |
| Shareholders' equity | ₩23B | ₩21B | ₩13B | ₩19B | ₩14B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩2.5B | ₩4.5B | ₩5.4B | ₩110M | −₩2.3B |
| Capital spending | ₩3.1B | ₩174M | — | — | — |
| Free cash flow | −₩574M | ₩4.3B | ₩5.4B | ₩110M | −₩2.3B |
Consolidated where available. Amounts in won.
Also known as: Nuvotec / 뉴보텍 / 060260 / KRX:060260
Source: KRX statistical information